|
Hadel Abo El Enin describes for SIIC the most significant aspects of his article describe para SIIC los aspectos relevantes de su artículo Single dose sublingual tablets for treatment stress hypertension FIXED DOSE SUBLINGUAL TABLETS FOR TREATMENT STRESS HYPERTENSION AND ANXIETY This study is concerned in treatment stress hypertension using fixed dose bi-therapy sublingual tablets. They contain bisoprolol hemifumarate as antihypertensive drug and buspirone hydrochloride as anxiolytic drug. Using sublingual tablets is hopeful to improve the BuHCl poor oral bioavailability and to facilitate administration to patients experiencing problems with swallowing. The article was published by El artículo fue publicado por
Principal institution where the research took place Institución principal de la investigación Pharmaceutics Department, National Organization of Drug Control and Research (NODCAR), Giza, Egypt, Giza, Giza, Egypt  Authors' Report Crónica del Autor Bibliographic references Referencias bibliográficas Aburahma MH, El-Laithy HM, Hamza Yel-S. Preparation and in vitro in vivo characterization of porous sublingual tablets containing ternary kneaded solid system of vinpocetine with î-cyclodextrin and hydroxyl Acid. Sci Pharm 78:363-379, 2010. Bi Y, Yonezawa Y, Sunada H. Rapidly disintegrating tablets prepared by the wet compression method: Mechanism and optimization. J Pharm Sci 88:1004-1010, 1999. Bodmeier R, Paeratakul O. Constant potassium chloride release from microporous membrane-coated tablets prepared with aqueous colloidal polymer dispersions. Pharm Res 8:355-359, 1991. Comoglu T, Dogan A, Comoglu S, Basci N. Formulation and evaluation of diclofenac potassium fast-disintegrating tablets and their clinical application in migraine patients. Drug Dev Ind Pharm 37:260-267, 2011. Cruickshank JM. Beta-blockers and heart failure. Indian Heart J 62:101-110, 2010. Farooq R, Haleem DJ, Haleem MA. Dose related effects of buspirone on serum electrolyte balance, plasma osmolality and systolic blood pressure (SBP) in rats. Pak J Pharm Sci 20:295-299, 2007. Gianaros PJ, Jennings JR, Sheu LK, Derbyshire SW, Matthews KA. Heightened functional neural activation to psychological stresscovaries with exaggerated blood pressure reactivity. Hypertension 49:134-140, 2007. Grigor'eva NIu, Sharabrin EG, Kuznetsov AN, Mazalov KV, Kontorshchikova KN, Koroleva EF. Effects of beta 1-adrenoblocker bisoprolol one endothelial dysfunction in patients with stable angina pectoris in combination with chronic obstructive pulmonary disease. TerArkh 81:28-31, 2009. Herman J, Remon JP. Aluminum magnesium hydroxide tablets: effect of processing and composition of granulating solution on the granule properties and in vitro antacid performance. Drug Dev Ind Pharm 14:1221-1234, 1988. Lim LW, Temel Y, Visser-Vandewalle V, Steinbusch H, Schruers K, Hameleers R, etal. Effect of buspirone on the behavioral regulation of rats in low versus high anxiety conditions. Arzneimittelforschung 58:269-276, 2008. Moore JW, Flanner HH. The comparison of dissolution profile. Pharm Tech 20:64-74, 1996. Qiu Z, Stowell JG, Morris KR, Byrn SR, Pinal R. Kinetic study of the Maillard reaction between metoclopramide hydrochloride and lactose. Int J Pharm 303:20-30, 2005. Rawas-Qalaji MM, Simons FE, Simons KJ. Fast-disintegrating sublingual tablets: Effect of epinephrine load on tablet characteristics. AAPS Pharm Sci Tech 7:E41, 2006. Sammour OA, Hammad MA, Megrab NA, Zidan AS. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS PharmSciTech 7:E55, 2006. Shingala JR, Balaraman R. Antihypertensive effect of 5HT1A agonist buspirone and 5HT2B antagonists in experimentally induced hypertension in rats. Pharmacology 73:129-139, 2005. Shukla D, Chakraborty S, Singh S, Mishra B. Fabrication and evaluation of taste masked resinate of risperidone and its orally disintegrating tablets. Chem Pharm Bull (Tokyo) 57:337-345, 2009. The United State Pharmacopoeia 33, N28, Rockville, MD: United States pharmacopeial, convention [1261] Twin brook parkaway; 2009. Pp. 256-259. SIIC System of Assisted Editing (SSEA) / Sistema SIIC de Edición Asistida (SSEA)
The article is strictly related to the following sections of siicsalud El artículo se relaciona estrictamente con las siguientes secciones de siicsalud
Information about the full text Acerca del trabajo completo Development and Evaluation of Fixed Dose Bi Therapy Sublingual Tablets for Treatment Stress Hypertension and Anxiety Author / Autor Hadel Abo El Enin1, Mohamed El-Nabarawi2, Saadeya Tayel3, Nadia Soliman4 4 Assistant Profrssor, Pharmaceutics Department, National Organization Of Drug Control And Research (nodcar), Giza, Egypt Access to the original source Journal of Pharmacy and BioAllied Sciences Article URL: / URL del artículo: http://www.jpbsonline.org URL of Abstract page in Medline: / URL del abstract en Medline: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778588/ siic DB: / siic DB: http://www.siicsalud.com/main/distriprinrel.php |
||||||||||||||||||||||
Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008
